| Robert L Miller, CRNA | |
|
15190 Community Rd, Suite 230a, Gulfport, MS 39503-3485 | |
| (228) 831-0204 | |
| (228) 831-1868 |
| Full Name | Robert L Miller |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 15190 Community Rd, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265694814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R767491 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Garden Park Medical Center | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singing River Gulfport | 5294154829 | 106 |
News Archive
Gov. Mark Dayton has promised to sign the legislation, which enables his administration to move forward on building the infrastructure necessary for the marketplace to begin enrolling people Oct. 1 - a tight deadline that officials said would require massive work to meet.
A study conducted at the Los Alamos National Laboratory, USA, and Concordia University, Canada, has explored the impact of different types of glycans on the interaction between SARS-CoV-2 spike protein and human ACE2 receptor.
Not only are Pacific oysters (Crassostrea gigas) a seafood delicacy, but they may also be key for helping scientists figure out how to stop the spread of coronaviruses.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
The YMCA of Greater New York today announced the New York City expansion of the YMCA's Diabetes Prevention Program, a 16-session group behavior change class that helps people at high risk for developing type 2 diabetes prevent the disease through healthy eating, increased activity and other positive lifestyle changes.
› Verified 5 days ago
| Entity Name | Lifelinc Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801021464 PECOS PAC ID: 0941347447 Enrollment ID: O20130522000277 |
News Archive
Gov. Mark Dayton has promised to sign the legislation, which enables his administration to move forward on building the infrastructure necessary for the marketplace to begin enrolling people Oct. 1 - a tight deadline that officials said would require massive work to meet.
A study conducted at the Los Alamos National Laboratory, USA, and Concordia University, Canada, has explored the impact of different types of glycans on the interaction between SARS-CoV-2 spike protein and human ACE2 receptor.
Not only are Pacific oysters (Crassostrea gigas) a seafood delicacy, but they may also be key for helping scientists figure out how to stop the spread of coronaviruses.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
The YMCA of Greater New York today announced the New York City expansion of the YMCA's Diabetes Prevention Program, a 16-session group behavior change class that helps people at high risk for developing type 2 diabetes prevent the disease through healthy eating, increased activity and other positive lifestyle changes.
› Verified 5 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1780312504 PECOS PAC ID: 5294154829 Enrollment ID: O20230106000462 |
News Archive
Gov. Mark Dayton has promised to sign the legislation, which enables his administration to move forward on building the infrastructure necessary for the marketplace to begin enrolling people Oct. 1 - a tight deadline that officials said would require massive work to meet.
A study conducted at the Los Alamos National Laboratory, USA, and Concordia University, Canada, has explored the impact of different types of glycans on the interaction between SARS-CoV-2 spike protein and human ACE2 receptor.
Not only are Pacific oysters (Crassostrea gigas) a seafood delicacy, but they may also be key for helping scientists figure out how to stop the spread of coronaviruses.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
The YMCA of Greater New York today announced the New York City expansion of the YMCA's Diabetes Prevention Program, a 16-session group behavior change class that helps people at high risk for developing type 2 diabetes prevent the disease through healthy eating, increased activity and other positive lifestyle changes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert L Miller, CRNA 15190 Community Rd, Suite 230a, Gulfport, MS 39503-3485 Ph: (228) 831-0204 | Robert L Miller, CRNA 15190 Community Rd, Suite 230a, Gulfport, MS 39503-3485 Ph: (228) 831-0204 |
News Archive
Gov. Mark Dayton has promised to sign the legislation, which enables his administration to move forward on building the infrastructure necessary for the marketplace to begin enrolling people Oct. 1 - a tight deadline that officials said would require massive work to meet.
A study conducted at the Los Alamos National Laboratory, USA, and Concordia University, Canada, has explored the impact of different types of glycans on the interaction between SARS-CoV-2 spike protein and human ACE2 receptor.
Not only are Pacific oysters (Crassostrea gigas) a seafood delicacy, but they may also be key for helping scientists figure out how to stop the spread of coronaviruses.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
The YMCA of Greater New York today announced the New York City expansion of the YMCA's Diabetes Prevention Program, a 16-session group behavior change class that helps people at high risk for developing type 2 diabetes prevent the disease through healthy eating, increased activity and other positive lifestyle changes.
› Verified 5 days ago
Kathryn Pittman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15200 Community Rd, Gulfport, MS 39503 Phone: 228-575-7000 | |
Jason Wells, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-865-3281 Fax: 228-867-5117 | |
Victor P Polito, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 15190 Community Rd, Suite 230a, Gulfport, MS 39503 Phone: 228-831-0204 Fax: 228-831-1868 | |
Glen Deitrick, C.R.N.A Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 15190 Community Rd, Suite 230a, Gulfport, MS 39503 Phone: 228-831-0204 Fax: 228-831-1868 | |
Glen Michael Cavalier, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15200 Community Rd, Gulfport, MS 39503 Phone: 228-575-7000 | |
Julie K Klester, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd, Suite 230a, Gulfport, MS 39503 Phone: 228-831-0204 Fax: 228-831-1868 | |
Trinh Thu Weatherly, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-4000 |